Search for: "In Re XENCOR, INC. " Results 1 - 4 of 4
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
In re Xencor: USPTO’s Inaction Following Federal Circuit Remand
3 Apr 2024, 9:13 am by Dennis Crouch
by Dennis Crouch On January 23, 2024, the Federal Circuit granted the USPTO’s request for a remand in the case of In re Xencor, Inc. [read post]
Patently-O - https://patentlyo.com
Motion for remand in Xencor
4 Dec 2023, 5:39 am by Dennis Crouch
In the pending Federal Circuit appeal In re Xencor, the USPTO Director recently filed an opposed motion asking the Court to remand the case back to the PTAB. [read post]
Patently-O - https://patentlyo.com
USPTO Granted Remand in Important Antibody Written Description Case
23 Jan 2024, 8:01 am by Dennis Crouch
In re Xencor, 23-2048 (Fed. [read post]
Patently-O - https://patentlyo.com
IP Think Tank Global Week in Review - 11 January 2008
11 Jan 2008, 9:00 am
: (Biotech Weblog),Immunomedics obtains antibody patent: (SmartBrief),Cyplasin Biomedical obtains US patent for protein based cancer treatment: (Patent Docs)Argatroban - Encysive Pharmaceuticals Inc., GlaxoSmithKline and Mitsubishi Chemical Corp. file patent infringement lawsuit to stop Barr Laboratories from producing a generic version of the anti-blood clotting drug: (IP Law360), Biaxin (Clarithromycin) - Court holds in Abbott Labs v Sandoz… [read post]
IP Thinktank - http://duncanbucknell.com/ipthinktank.blog